FilingReader Intelligence
Aurobindo denies $5.5bn Zentiva buyout reports
August 20, 2025 at 05:49 AM UTC•By FilingReader AI
Aurobindo Pharma denied reports of a $5.5bn Zentiva buyout, calling the news "premature and unreliable."
The company said it regularly explores acquisitions but confirmed no binding agreement or board decision has been made regarding the transaction.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:AUROPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Aurobindo Pharma publishes news
Free account required • Unsubscribe anytime